Jobs / United States / Astrazeneca Pharmaceuticals Lp
BISO - Manufacturing, Operations & Enabling
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Are you ready to safeguard the digital backbone that keeps medicines moving from development to patients? This is your opportunity to be AstraZeneca’s primary strategic cybersecurity partner across two critical portfolios—regulated manufacturing environments and enterprise business applications—where every security decision helps protect product quality, patient safety, financial integrity, and business continuity. In this customer-facing role, you will represent the CISO and lead engagement, alignment, and delivery of cybersecurity risk and resilience outcomes. You will guide security priorities and long-term posture across operational technology and manufacturing execution systems, as well as enterprise SaaS platforms such as Workday, SAP, Coupa, and Concur. Can you balance the realities of 24/7 production with the pace of cloud/SaaS innovation to achieve measurable, inspection-ready results? Accountabilities • Dual-Portfolio Strategic Partnership: Serve as the lead security partner to Manufacturing Operations IT and Enabling Units IT leadership, shaping governance forums to drive risk-based decisions, clear accountability, and visible security outcomes across both portfolios. • Risk Posture and Architecture: Guide architects to define layered security approaches suited to each environment—industrial security architecture for plants and cloud-native controls for enterprise SaaS—so that controls are effective, pragmatic, and scalable. • Manufacturing Technology Security: Lead security for operational technology, industrial control systems, and manufacturing execution systems, implementing segmentation, secure remote access, and privileged access practices that respect validation and uptime requirements. • Enterprise SaaS and Cloud Security: Drive security consulting and risk management for Workday, SAP, Coupa, Concur and other enterprise platforms, covering identity and access management, data protection, integration security, privileged access governance, and vendor assurance. • Regulatory and Compliance Alignment: Embed controls aligned to GMP/GxP and computerized system validation in manufacturing, financial controls and SOX for Finance, GDPR for employee data, and due diligence requirements for Legal and M&A—demonstrating audit- and inspection-ready evidence. • Validation-Aware and Change-Controlled Delivery: Ensure security improvements align to validation and change control processes, with impact assessments, documentation, and compensating controls that maintain production continuity and business operations. • Asset Visibility and Vulnerability Management: Establish comprehensive inventories and risk-based vulnerability management across both manufacturing technology and SaaS/cloud platforms, reducing critical exposures while respecting patching and update constraints. • Integration and Data Flow Security: Secure data flows from shop-floor to enterprise and across business applications (HR-to-Finance, procurement-to-payment), with strong identity controls, logging, monitoring, and resilience patterns. • Third-Party and Vendor Risk Management: Strengthen supplier risk management for automation vendors, equipment manufacturers, SaaS providers, cloud platforms, and business service partners through enforceable minimum controls, ongoing assurance, and secure support models. • Incident Preparedness, Response, and Recovery: Collaborate with security operations and business teams to create environment-specific playbooks, run tabletop exercises, and improve recovery readiness for production-critical and business-critical services. • Inspection and Audit Readiness: Maintain evidence aligned to GMP expectations and audit requirements for financial controls, SOX, data privacy, and M&A due diligence to ensure continual re